Trials / Conditions / Metastatic Microsatellite-stable Colorectal Cancer
Metastatic Microsatellite-stable Colorectal Cancer
6 registered clinical trials studyying Metastatic Microsatellite-stable Colorectal Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | LB-100 (PP2A Inhibitor) and Atezolizumab (PD-L1 Inhibitor) in Metastatic Colorectal Cancer Patients NCT06012734 | The Netherlands Cancer Institute | Phase 1 |
| Recruiting | Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC NCT05768503 | Sun Yat-sen University | Phase 3 |
| Active Not Recruiting | Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Me NCT05205330 | Rottapharm Biotech | Phase 1 / Phase 2 |
| Unknown | Sintilimab and Chidamide in Combination With or Without IBI305 in Advanced or Metastatic pMMR/MSS Colorectal C NCT04724239 | Sun Yat-sen University | Phase 2 |
| Unknown | Nivolumab+Ipilimumab+RT in MSS mCRC NCT04575922 | Massachusetts General Hospital | Phase 2 |
| Active Not Recruiting | COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy i NCT04068610 | MedImmune LLC | Phase 1 / Phase 2 |